GRP logo
Quantitative Risk-Benefit Methods

Quantitative Risk-Benefit Methods for Assessing Drug Safety and Efficacy: Report of the ISPOR Risk-Benefit Management Working Group

The citation for this report is:
Guo JJ, Pandey S, Doyle J, et al. A review of quantitative risk-benefit methodologies for assessing drug safety and efficacy – Report of the ISPOR Risk-Benefit Management Working Group. Value in Health 2010; 13(5):657-666.

Translations: » 中文

Working Group Chair:
Jeff J. Guo, PhD, Professor, University of Cincinnati Health Academic Center, College of Pharmacy, Cincinnati, OH, USA

Leadership Group:
Swapnil Pandy, MS, Kendle International Inc, Cincinnati, OH, USA
John Doyle, PhD, Department of Epidemiology, Mailman School of Public Health, Columbia University, New York NY, USA, and Centre for Socioeconomics Research, Welsh School of Pharmacy, Cardiff, UK
Boyang Bian, MS, University of Cincinnati Health Academic Center, College of Pharmacy, Cincinnati, OH, USA
Yvonne Lis, PhD, Centre for Socioeconomic Research, Welsh School of Pharmacy, Cardiff, UK
Dennis W. Raisch, PhD, University of New Mexico, College of Pharmacy, Albuquerque, NM, USA


ISPOR Good Practices For Outcomes Research Index